Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Ganesh Pawar Article rating: 3.6

The market opened in green on February 15, 2021, overall volumes in futures & options currently stand at 2,09,89,787 contracts with a turnover of Rs. 20,59,106.43 crore.

Markets waiting for a trigger point
Markets waiting for a trigger point

Markets waiting for a trigger point

Karan Dsij Article rating: 4.6

The last week of trading was a very unique one as out of the five trading sessions, Nifty had formed an indecisive bar in three sessions. The index traded within a narrow range of 280 points throughout the week, but within this narrow range, tremors of volatility were witnessed.

IPO analysis: RailTel Corporation of India
IPO analysis: RailTel Corporation of India

IPO analysis: RailTel Corporation of India

Ganesh V Article rating: 3.4

RailTel is a Miniratna (Category- I) central public sector enterprise, which is wholly-owned by the Government of India and comes under the administrative control of the Ministry of Railways. It is hitting the primary capital market with its IPO. Read on to find out whether you should subscribe to the issue or not. 

CDSL gives trendline breakout
CDSL gives trendline breakout

CDSL gives trendline breakout

Vinayak Gangule Article rating: 4.2

The stock's relative strength index (RSI) has reached its highest value in the last 14-days, which is bullish. Also, it has managed to close above the 60 mark after a span of almost 23 trading sessions. The MACD is above the zero line and signal line. The MACD histogram suggests bullish momentum.

Biocon Biologics & Viatris receive nod for Kixelle-biosimilar insulin Aspart from EC
Biocon Biologics & Viatris receive nod for Kixelle-biosimilar insulin Aspart from EC

Biocon Biologics & Viatris receive nod for Kixelle-biosimilar insulin Aspart from EC

Ganesh V Article rating: 4.0

Biocon Biologics Ltd, a subsidiary of Biocon Ltd has announced that Kixelle, a biosimilar Insulin Aspart co-developed with Viatris Inc has received marketing authorisation approval from European Commission. The authorisation granted by EC is valid in all the EU member states. 

RSS
First18391840184118421844184618471848Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR